Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

The Job Market’s Next Chapter: Where Workers Are Still in Demand

Kory Kantenga, Head of Economics, Americas at LinkedIn, breaks down hiring trends, labor-market resilience and where employers are still seeking workers.

AI Investing Takes Off: Why Younger Investors Are Turning to AI for Research

Bret Kenwell, U.S. Investment and Options Analyst at eToro, breaks down how younger investors are using AI and where they’re looking beyond Big Tech.

Why Americans Are Spending More on Hobbies Despite Economic Pressure

Joe Wadford, Economist at Bank of America, breaks down the hobby spending boom, “funflation” and why millennials and Gen Z spend differently.

Vanessa Hudgens’ Next Big Role? Building a Cactus Water Brand

Vanessa Hudgens and Oliver Trevena, co-founders of Caliwater, reveal why they’re betting on cactus water, the rise of healthy beverages and plans to grow bigger

Is The Stock Market Rally Running On Borrowed Time?

Adam Turnquist, Chief Cross-Asset Strategist at LPL Financial, breaks down why stocks remain near records despite higher oil prices, rates and Fed tightening.

Graco Turns 100: How Its Industrial Tech Is Powering the AI Boom

Graco CEO Mark Sheahan explains how the 100-year-old company is expanding into AI infrastructure, data centers and advanced manufacturing.

Load More